12
Participants
Start Date
June 1, 2023
Primary Completion Date
July 31, 2025
Study Completion Date
December 31, 2025
Cerebrolysin
30 ml cerebrolysin + 70 ml normal saline, days 4-17, once/day, intravenously
Control
100 ml normal saline, days 4-17, once/day, IV
Konkuk University Medical Center Research Coordinating Center, Seoul
Collaborators (1)
Ever Neuro Pharma GmbH
INDUSTRY
Konkuk University Medical Center
OTHER